Articles

• New diagnostic criteria for multiple sclerosisApplication in first demyelinating episode

  M. Tintoré, A. Rovira, J. Río, C. Nos, E. Grivé, J. Sastre-Garriga, I. Pericot, E. Sánchez, M. Comabella, X. Montalban

  • Abstract
  • Full Text
  • Full Text (PDF)
• Measuring the impact of MS on walking abilityThe 12-Item MS Walking Scale (MSWS-12)

  J. C. Hobart, A. Riazi, D. L. Lamping, R. Fitzpatrick, A. J. Thompson

  • Abstract
  • Full Text
  • Full Text (PDF)
• Neutralizing antibodies during treatment of secondary progressive MS with interferon β-1b

  C. Polman, L. Kappos, R. White, F. Dahlke, K. Beckmann, C. Pozzilli, A. Thompson, J. Petkau, D. Miller

  • Abstract
  • Full Text
  • Full Text (PDF)
• Interferon β-1a in primary progressive MSAn exploratory, randomized, controlled trial

  S.M. Leary, D.H. Miller, V.L. Stevenson, P.A. Brex, D.T. Chard, A.J. Thompson

  • Abstract
  • Full Text
  • Full Text (PDF)
• IFNβ lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS

  E. Waubant, D. Goodkin, A. Bostrom, P. Bacchetti, J. Hietpas, R. Lindberg, D. Leppert

  • Abstract
  • Full Text
  • Full Text (PDF)
• Hereditary infantile hemiparesis, retinal arteriolar tortuosity, and leukoencephalopathy

  K. Vahedi, P. Massin, J.-P. Guichard, S. Miocque, M. Polivka, F. Goutières, D. Dress, F. Chapon, M.-M. Ruchoux, F. Riant, A. Joutel, A. Gaudric, M.-G. Bousser, E. Tournier-Lasserve

  • Abstract
  • Full Text
  • Full Text (PDF)
• Awareness, treatment, and control of vascular risk factors in African Americans with stroke

  S. Ruland, R. Raman, S. Chaturvedi, S. Leurgans, P. B. Gorelick

  • Abstract
  • Full Text
  • Full Text (PDF)
• Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD

  J.G. Nutt, K.J. Burchiel, C.L. Comella, J. Jankovic, A.E. Lang, E.R. Laws, A.M. Lozano, R.D. Penn, R.K. Simpson, M. Stacy, G.F. Wooten, the ICV GDNF Study Group*

  • Abstract
  • Full Text
  • Full Text (PDF)
• Brain parenchyma sonography discriminates Parkinson’s disease and atypical parkinsonian syndromes

  U. Walter, L. Niehaus, T. Probst, R. Benecke, B. U. Meyer, D. Dressler

  • Abstract
  • Full Text
  • Full Text (PDF)
• How do parkinsonian signs return after discontinuation of subthalamic DBS?

  P. Temperli, J. Ghika, J.-G. Villemure, P.R. Burkhard, J. Bogousslavsky, F.J.G. Vingerhoets

  • Abstract
  • Full Text
  • Full Text (PDF)
• Longitudinal changes in verbal memory in older adultsDistinguishing the effects of age from repeat testing

  Melissa Lamar, Susan M. Resnick, Alan B. Zonderman

  • Abstract
  • Full Text
  • Full Text (PDF)
• The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism

  J.C. Pressley, E.D. Louis, M.-X. Tang, L. Cote, P.D. Cohen, S. Glied, R. Mayeux

  • Abstract
  • Full Text
  • Full Text (PDF)
• fMRI identifies regional specialization of neural networks for reading in young children

  W.D. Gaillard, L.M. Balsamo, Z. Ibrahim, B.C. Sachs, B. Xu

  • Abstract
  • Full Text
  • Full Text (PDF)
• Regional brain chemical alterations in young children with autism spectrum disorder

  S.D. Friedman, D.W. Shaw, A.A. Artru, T.L. Richards, J. Gardner, G. Dawson, S. Posse, S.R. Dager

  • Abstract
  • Full Text
  • Full Text (PDF)
• The spectrum of neuropathy in diabetes and impaired glucose tolerance

  C.J. Sumner, S. Sheth, J.W. Griffin, D.R. Cornblath, M. Polydefkis

  • Abstract
  • Full Text
  • Full Text (PDF)